The effect of Onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenografts

European Journal of Cancer Part A

Volumn 33, Issue 7, 1997, Pages 1130-1135

  Jacobs, E ^a   Watson, S A ^b   Ellis, I O ^a   Hardcastle, J D ^b   Robertson, J F R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Colorectal; Female; Gastric; Male; Oestrogen; Onapristone; Progesterone antagonist; Xenograft tumours

Indexed keywords

ANTIGESTAGEN; ESTRADIOL; ONAPRISTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; GROWTH RATE; GROWTH STIMULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; ESTROGENS; FEMALE; GASTROINTESTINAL NEOPLASMS; GONANES; HUMANS; MALE; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; RANDOM ALLOCATION; RECEPTORS, PROGESTERONE; SEX FACTORS; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0030859232     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00070-1     Document Type: Article

References (17)

1. Neef G, Beier S, Elger W, Henderson D, Wiechert R. New Steroids with anti-progestational and antiglucocorticoid activities. Steroids 1984, 44, 39-372.
2. Schneider MR, Michna H, Nishino Y, El Etreby MF. Antitumor activity of the progesterone antagonists ZK98.299 and RU486 in the hormone dependent MXT mammary tumor of the mouse and the DBMA- and MNU-induced mammary tumor model of the rat. Eur J Cancer Clin Oncol 1989, 25, 691-701.
3. Michna H, Gehring S, Kuhnel W, Nishino Y, Schneider MR. The antitumor potency of progesterone antagonists is due to their differentiation potential. J Steroid Biochem Mol Biol 1992, 43, 203-210.
4. Klijn JGM, de Jong FH, Bakker GH, Lamberts SWJ, Rodenberg CJ, Alexieva-Figusch J. Antiprogestins, a new form of endocrine therapy for human breast cancer. Cancer Res 1989, 49, 2851-2856.
5. Jacobs E, Watson SA, Hardcastle JD, Robertson JFR. In vivo studies: sex differences in the growth of gastrointestinal tumours (abstract). Gut (suppl 2) 1995, 37, A37.
6. Cormier EM, Wolf MF, Craig Jordan V. Decrease in estradiol-stimulated progesterone receptor production in MCF7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth. Cancer Res 1989, 49, 576-580.
7. Jacobs E, Watson SA, Hardcastle JD, Robertson JFR. Oestrogen and progesterone receptors in gastrointestinal cancer cell lines. Eur J Cancer 1996, 32A, 2348-2353.
8. Watson SA, Durrant LG, Wencyk PM, Watson AL, Morris DL. Intracellular gastrin in human gastro-intestinal tumour cells. J Natl Cancer Inst 1991, 83, 866-871.
9. Hojo J. Establishment of cultured cell lines of human stomach cancer origin and their morphological characteristics. Niigata Igakukai Zasshi 1977, 91, 737.
10. Durrant LG, Robins RA, Pimm MV, et al. Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer 1986, 53, 37-45.
11. Watson SA, Michaeli D, Grimes S, et al. Anti-gastrin antibodies raised by Gastrimmune inhibit growth of the human colorectal tumour AP5. Int J Cancer 1995, 61, 233-240.
12. Vollmer G, Michna H, Ebert K, Knuppen R. Down-regulation of tenascin expression by antiprogestins during terminal differentiation of rat mammary tumours. Cancer Res 1992, 52, 4642-4648.
13. Vollmer G, Michna H, Schneider MR, Knuppen R. Stromal expression of tenascin is inversely correlated to epithelial differentiation of hormone dependent tissues. J Steroid Biochem Mol Biol 1994, 48, 487-494.
14. Westley BR, May FEB. General review: Role of insulin-like growth factors in steroid modulated proliferation. J Steroid Biochem Mol Biol 1994, 51, 1-9.
15. Michna H, Nishino Y, Neef G, McGuire WL, Schneider MR. Progesterone antagonists: tumour-inhibiting potential and mechanism of action. J Steroid Biochem Mol Biol 1992, 41, 339-348.
16. Classen S, Possinger K, Pelka-Fleischer R, Wilmanns W. Effect of Onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells. J Steroid Biochem Mol Biol 1993, 45, 315-319.
17. Szende B, Lapis K, Redding TW, Srkalovic G, Schally AV. Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogues of LH-RH and somatostatin. Br Cancer Res Treat 1989, 14, 307-314.